chlorpromazine has been researched along with naloxone in 59 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 38 (64.41) | 18.7374 |
| 1990's | 4 (6.78) | 18.2507 |
| 2000's | 7 (11.86) | 29.6817 |
| 2010's | 10 (16.95) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Gozalbes, R; Pineda-Lucena, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Holtzman, SG | 1 |
| Paalzow, G; Paalzow, L | 1 |
| Gebhart, GF; Lewis, VA | 1 |
| Durham, HD; Frank, GB; Marwaha, J | 1 |
| Extein, I; Goodwin, FK; Lo, C; Schoenfeld, RI | 1 |
| Stretch, R | 2 |
| Bhargava, HN | 1 |
| Angelucci, L; Valeri, P | 1 |
| McKearney, JW | 1 |
| Carlson, KR; Eibergen, RD | 1 |
| Haigler, HJ | 1 |
| Aiken, JW; Frederickson, RC; Hewes, CR | 1 |
| Negus, SS; Picker, MJ; Powell, KR | 1 |
| Blumer, JL; Buck, ML | 1 |
| Belczynski, CR; Casey, KL; Morrow, TJ; Pertovaara, A | 1 |
| Hikasa, Y; Ogasawara, S; Takase, K | 1 |
| Casey, KL; Kiritsy-Roy, JA; Lin, Y; Morrow, TJ; Terry, LC | 1 |
| Aihara, H; Araki, H | 1 |
| Li, BH; Yang, XY | 1 |
| Byrd, LD; Howell, LL; Standish, LJ | 1 |
| Chandavasu, O; Chatkupt, S | 1 |
| Myers, DE; Myslinski, NR; Wynn, RL | 1 |
| Bell, RD; Cicero, TJ; Meyer, ER | 1 |
| Aghajanian, GK; Bunney, BS; Korf, J | 1 |
| Kamei, C; Shimomura, K; Ueki, S | 1 |
| Fraser, HF | 1 |
| McMillan, DE | 1 |
| Gebhart, GF; Sherman, AD | 1 |
| Carmichael, FJ; Israel, Y | 1 |
| Mitchell, CL; Sherman, AD | 1 |
| Hornykiewicz, O; Kuschinsky, K | 1 |
| Demura, R; Kanda, M; Miki, N; Miyoshi, H; Ohmura, E; Shizume, K; Wakabayashi, I | 1 |
| Weller, MP; Wright, DJ | 1 |
| Dubinsky, B; Janssen, PA; McGuire, JL; McKenzie, BE; Niemegeers, CJ; Weintraub, HS | 1 |
| Johnson, C; Mitchell, J; Stuckey, M | 1 |
| Jakoubek, B | 1 |
| Dulawa, J; Grzeszczak, W; Kokot, F | 1 |
| Silverstone, T | 1 |
| Bain, G; Kornetsky, C | 1 |
| Esposito, RU; Kornetsky, C; Perry, W | 1 |
| Gupta, MC; Singh, J | 1 |
7 review(s) available for chlorpromazine and naloxone
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Phenothiazine-associated apnea in two siblings.
Topics: Apnea; Bradycardia; Chlorpromazine; Drug Therapy, Combination; Family; Female; Humans; Infant; Male; Meperidine; Naloxone; Phenothiazines; Promethazine; Urinary Tract Infections | 1991 |
Certain theoretical and practical considerations involved in evaluating the overall abuse potential of opiate agonists and antagonists.
Topics: Animals; Chlorpromazine; Codeine; Cyclazocine; Drug Combinations; Drug Evaluation; Drug Evaluation, Preclinical; Humans; Lysergic Acid Diethylamide; Mice; Morphinans; Morphine; Morphine Dependence; Nalorphine; Naloxone; Narcotic Antagonists; Pentobarbital; Rats; Receptors, Drug; Species Specificity; Substance Withdrawal Syndrome; Substance-Related Disorders; Surveys and Questionnaires | 1973 |
Effects of narcotics and narcotic antagonists on operant behavior.
Topics: Animals; Avoidance Learning; Behavior, Animal; Chlorpromazine; Columbidae; Conditioning, Operant; Cyclazocine; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Drug Tolerance; Humans; Methadone; Morphine; Nalorphine; Naloxone; Narcotic Antagonists; Narcotics; Pentazocine; Rats; Reinforcement Schedule; Substance Withdrawal Syndrome | 1973 |
Psychopharmacological treatment of anorexia nervosa and bulimia. Review and synthesis.
Topics: Adrenocorticotropic Hormone; Anorexia Nervosa; Antidepressive Agents, Tricyclic; Chlorpromazine; Cyproheptadine; Dopamine; Feeding and Eating Disorders; Female; Humans; Hyperphagia; Levodopa; Lithium; Lithium Carbonate; Male; Naloxone; Phenytoin; Pimozide; Serotonin; Zinc | 1983 |
Psychopharmacology of hunger and food intake in humans.
Topics: Amitriptyline; Amphetamine; Appetite Depressants; Chlorpromazine; Cholecystokinin; Cyproheptadine; Eating; Feeding Behavior; Fenfluramine; Humans; Hunger; Insulin; Lithium; Naloxone | 1982 |
52 other study(ies) available for chlorpromazine and naloxone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Failure of naloxone to modify the effects of chlorpromazine and d-amphetamine on avoidance behavior in the squirrel monkey.
Topics: Animals; Avoidance Learning; Chlorpromazine; Dextroamphetamine; Drug Interactions; Female; Haplorhini; Naloxone; Saimiri | 1979 |
Clonidine antinociceptive activity: effects of drugs influencing central monoaminergic and cholinergic mechanisms in the rat.
Topics: 5-Hydroxytryptophan; Analgesia; Animals; Atropine; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Brain Chemistry; Chlorpromazine; Clonidine; Electroshock; Fenclonine; Lysergic Acid Diethylamide; Male; Methyltyrosines; Naloxone; Parasympathetic Nervous System; Phenoxybenzamine; Rats; Receptors, Adrenergic; Receptors, Cholinergic; Reserpine; Sympathetic Nervous System; Vocalization, Animal; Yohimbine | 1976 |
Evaluation of the periaqueductal central gray (PAG) as a morphine-specific locus of action and examination of morphine-induced and stimulation-produced analgesia at coincident PAG loci.
Topics: Analgesia; Animals; Cerebral Aqueduct; Chlordiazepoxide; Chlorpromazine; Dose-Response Relationship, Drug; Male; Morphine; Naloxone; Pentobarbital; Rats; Receptors, Opioid | 1977 |
Effects of antipsychotic drugs on action potential production in skeletal muscle. II. Haloperidol: nonspecific and opiate drug receptor mediated effects.
Topics: Action Potentials; Animals; Anura; Chlorpromazine; Electric Stimulation; Haloperidol; In Vitro Techniques; Muscles; Naloxone; Rana pipiens; Receptors, Opioid; Sodium; Time Factors | 1977 |
Dopamine-mediated behavior produced by the enkephalin analogue FK 33-824.
Topics: Animals; Apomorphine; Chlorpromazine; D-Ala(2),MePhe(4),Met(0)-ol-enkephalin; Dopamine; Dose-Response Relationship, Drug; Endorphins; Enkephalins; Haloperidol; Humans; Male; Naloxone; Rats; Receptors, Dopamine; Receptors, Opioid; Stereotyped Behavior | 1979 |
Discrete-trial control of morphine self-injection behaviour in squirrel monkeys: effects of naloxone, morphine, and chlorpromazine.
Topics: Animals; Behavior, Animal; Chlorpromazine; Dose-Response Relationship, Drug; Drug Interactions; Haplorhini; Injections, Intravenous; Male; Morphine; Naloxone; Saimiri; Self Administration; Time Factors | 1977 |
Discrete-trial control of cocaine self-injection behaviour in squirrel monkeys: effects of morphine, naloxone, and chlorpromazine.
Topics: Animals; Behavior, Animal; Chlorpromazine; Cocaine; Dose-Response Relationship, Drug; Drug Interactions; Haplorhini; Male; Morphine; Naloxone; Reinforcement Schedule; Saimiri; Self Administration; Time Factors | 1977 |
Modification of pharmacological and toxicological effects of acetophenazine, chlorpromazine and thloridazine in morphine-dependent mice.
Topics: Animals; Body Temperature; Body Weight; Chlorpromazine; Humans; Lethal Dose 50; Male; Mice; Morphine Dependence; Motor Activity; Naloxone; Phenothiazines; Thioridazine | 1979 |
Influence of social environment and of drugs on 3H-corticosterone uptake in various brain areas.
Topics: Animals; Brain; Chlorpromazine; Corticosterone; Female; Humans; Limbic System; Male; Metergoline; Mice; Morphine; Naloxone; Propranolol; Rats; Receptors, Glucocorticoid; Receptors, Steroid; Social Environment; Stress, Psychological; Tritium | 1978 |
Drug effects and the environmental control of behavior.
Topics: Animals; Behavior, Animal; Chlorpromazine; Electroshock; Environment; Haplorhini; Lysergic Acid Diethylamide; Nalorphine; Naloxone; Narcotic Antagonists; Propylamines; Reinforcement Schedule | 1975 |
Dyskinesias in monkeys: interaction of methamphetamine with prior methadone treatment.
Topics: Animals; Chlorpromazine; Clozapine; Diazepam; Dyskinesia, Drug-Induced; Haloperidol; Haplorhini; Humans; Macaca mulatta; Male; Methadone; Methamphetamine; Naloxone; Phenobarbital; Phentolamine; Physostigmine; Spiperone; Stereotyped Behavior | 1976 |
Morphine: ability to block neuronal activity evoked by a nociceptive stimulus.
Topics: Action Potentials; Animals; Brain Stem; Chlorpromazine; Levorphanol; Male; Methadone; Morphine; Naloxone; Oxymorphone; Pain; Pentobarbital; Rats; Reticular Formation | 1976 |
Correlation between the in vivo and an in vitro expression of opiate withdrawal precipitated by naloxone: their antagonism by l-(-)-delta9-tetrahydrocannabinol.
Topics: Acetylcholine; Animals; Chlorpromazine; Codeine; Dose-Response Relationship, Drug; Dronabinol; Female; Guinea Pigs; Humans; Hypnotics and Sedatives; In Vitro Techniques; Male; Morphine; Motor Activity; Muscle Contraction; Muscle, Smooth; Naloxone; Pentazocine; Pentobarbital; Rats; Species Specificity; Stereoisomerism; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 1976 |
Differential cross-tolerance to mu and kappa opioid agonists in morphine-tolerant rats responding under a schedule of food presentation.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Benzomorphans; Chlorpromazine; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Tolerance; Ethylketocyclazocine; Fentanyl; Food; Male; Methadone; Morphine; Naloxone; Narcotics; Pyrrolidines; Rats; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Reinforcement Schedule | 1991 |
The effect of systemic cocaine on the responses to noxious stimuli and spontaneous activity of medial bulboreticular projection neurons.
Topics: Animals; Chlorpromazine; Cocaine; Electric Stimulation; Electroshock; Evoked Potentials; Male; Medulla Oblongata; Microelectrodes; Naloxone; Neurons; Raphe Nuclei; Rats; Rats, Inbred Strains; Reticular Formation; Spinal Cord | 1990 |
Evidence for the involvement of alpha 2-adrenoceptors in the emetic action of xylazine in cats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Atropine; Cat Diseases; Cats; Chlorpromazine; Diphenhydramine; Domperidone; Female; Hydroxydopamines; Male; Naloxone; Oxidopamine; Propranolol; Random Allocation; Receptors, Adrenergic, alpha; Thiazines; Vomiting; Xylazine | 1989 |
Cocaine: evidence for supraspinal, dopamine-mediated, non-opiate analgesia.
Topics: Analgesia; Animals; Benzazepines; Blood Pressure; Brain; Chlorpromazine; Cocaine; Heart Rate; Male; Naloxone; Pain; Rats; Rats, Inbred Strains; Receptors, Dopamine; Salicylamides | 1989 |
Effects of morphine and neuroleptics on wet-dog shaking behavior elicited by hippocampal stimulation in rats.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Chlorpromazine; Dose-Response Relationship, Drug; Electric Stimulation; Haloperidol; Hippocampus; Male; Morphine; Naloxone; Rats; Rats, Inbred Strains | 1985 |
[Inhibitory action of morphine and chlorpromazine on defecation in mice].
Topics: Amphetamine; Animals; Chlorpromazine; Defecation; Mice; Morphine; Naloxone | 1986 |
Behavioral effects of phencyclidine and ketamine alone and in combination with other drugs.
Topics: Animals; Atropine; Atropine Derivatives; Behavior, Animal; Chlorpromazine; Dextroamphetamine; Drug Interactions; Ketamine; Male; Naloxone; Phencyclidine; Saimiri | 1987 |
Central nervous system depression from chlorpromazine poisoning: successful treatment with naloxone.
Topics: Central Nervous System; Child, Preschool; Chlorpromazine; Coma; Depression, Chemical; Gastric Lavage; Humans; Male; Naloxone | 1985 |
The effect of fentanyl on the lick/chew response in rabbits.
Topics: Animals; Chlorpromazine; Dental Pulp; Electric Stimulation; Fentanyl; Mastication; Naloxone; Rabbits | 1985 |
Effects of phenoxybenzamine on the narcotic withdrawal syndrome in the rat.
Topics: Adrenergic beta-Antagonists; Animals; Behavior, Animal; Body Weight; Chlorpromazine; Depression, Chemical; Dose-Response Relationship, Drug; Haloperidol; Humans; Male; Morphine Dependence; Naloxone; Pentobarbital; Phenoxybenzamine; Phentolamine; Promethazine; Propranolol; Rats; Substance Withdrawal Syndrome; Time Factors | 1974 |
Noradrenergic neurons: morphine inhibition of spontaneous activity.
Topics: Animals; Cerebral Ventricles; Chlorpromazine; Dextroamphetamine; Dose-Response Relationship, Drug; Electrodes; Gallamine Triethiodide; Male; Morphine; Naloxone; Neurons; Norepinephrine; Pressure; Rats; Receptors, Drug | 1974 |
Significance of withdrawal jumping response in predicting physical dependence in mice.
Topics: Amitriptyline; Animals; Atropine; Cannabis; Chlordiazepoxide; Chlorpromazine; Diazepam; Humans; Imipramine; Male; Mephenesin; Methamphetamine; Mice; Morphine Dependence; Naloxone; Pentobarbital; Perphenazine; Phenytoin; Reserpine; Substance Withdrawal Syndrome | 1973 |
Pain-induced alteration of glutamate in periaqueductal central gray and its reversal by morphine.
Topics: Animals; Chlorpromazine; Glutamates; Hypothalamus; Male; Mice; Morphine; Naloxone; Nociceptors; Pain; Pentobarbital; Periaqueductal Gray | 1974 |
In vitro inhibitory effects of narcotic analgesics and other psychotropic drugs on the active uptake of norepinephrine in mouse brain tissue.
Topics: Animals; Atropine; Benztropine; Brain; Chlorpromazine; Cocaine; Codeine; Desipramine; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Levorphanol; Lipids; Meperidine; Methadone; Mice; Morphine; Naloxone; Narcotics; Norepinephrine; Solubility; Synaptosomes; Tritium | 1973 |
Effect of morphine on regional levels of gamma-hydroxybutyrate in mouse brain.
Topics: Animals; Brain; Brain Chemistry; Chlorpromazine; Chromatography, Gas; Dose-Response Relationship, Drug; Drug Tolerance; Hot Temperature; Hydroxybutyrates; Injections, Intraperitoneal; Male; Mice; Morphine; Naloxone; Pentobarbital; Reaction Time; Stimulation, Chemical; Time Factors | 1974 |
Morphine catalepsy in the rat: relation to striatal dopamine metabolism.
Topics: Animals; Apomorphine; Brain Chemistry; Catalepsy; Chlorpromazine; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Humans; Male; Methadone; Morphine; Motor Activity; Naloxone; Narcotic Antagonists; Rats; Rats, Inbred Strains | 1972 |
Effects of chlorpromazine and naloxone on growth hormone secretion in rats.
Topics: Animals; Antibodies; Chlorpromazine; Endorphins; Growth Hormone; Immunity, Maternally-Acquired; Male; Naloxone; Rats; Somatostatin | 1980 |
Neuropharmacological agents modifying endotoxin-induced changes in mice.
Topics: Adrenergic beta-Antagonists; Animals; Antidepressive Agents; Chlorpromazine; Dopamine Antagonists; Endotoxins; Erythrocyte Count; Histamine; Mice; Naloxone; Platelet Count; Receptors, Adrenergic, beta; Serotonin | 1980 |
Bromperidol, a new butyrophenone neuroleptic: a review.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Binding, Competitive; Biotransformation; Brain; Chlorpromazine; Dogs; Female; Half-Life; Haloperidol; Male; Mice; Naloxone; Rats; Receptors, Dopamine; Receptors, Opioid | 1982 |
Analgesia induced by painful stimulation and/or anticipation of pain; different mechanisms are operating.
Topics: Analgesia; Animals; Chlorpromazine; Dexamethasone; Diazepam; Electric Stimulation; Humans; Naloxone; Pain; Rats; Rats, Inbred Strains; Reaction Time; Stress, Physiological; Stress, Psychological | 1984 |
Influence of naloxone on prolactin secretion in patients with acute and chronic renal failure.
Topics: Acute Kidney Injury; Adult; Chlorpromazine; Female; Humans; Kidney Failure, Chronic; Male; Naloxone; Prolactin | 1984 |
Biobehavioral bases of the reinforcing properties of opiate drugs.
Topics: Animals; Brain; Chlorpromazine; Drug Tolerance; Electric Stimulation; Humans; Morphine; Naloxone; Narcotics; Opioid-Related Disorders; Rats; Reinforcement, Psychology; Reward; Self Stimulation; Sensory Thresholds | 1982 |
Chlorpromazine and brain-stimulation reward: potentiation of effects by naloxone.
Topics: Animals; Brain; Chlorpromazine; Dose-Response Relationship, Drug; Drug Synergism; Electric Stimulation; Male; Naloxone; Rats; Reward; Self Stimulation; Sensory Thresholds | 1981 |
Effect of aspartate and glutamate on nociception, catalepsy and core temperature in rats.
Topics: Adrenergic Uptake Inhibitors; Analgesia; Analgesics, Opioid; Animals; Aspartic Acid; Body Temperature; Catalepsy; Chlorpromazine; Dopamine Antagonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fever; Glutamic Acid; Haloperidol; Hypothermia; Injections, Subcutaneous; Ketamine; Male; Morphine; Naloxone; Narcotic Antagonists; Nociceptors; Rats; Reserpine; Trifluoperazine | 1997 |